Publications by authors named "Teppei Sugano"

Claim this Profile
A
A Case of Binocular Metastatic Choroidal Tumor Originating from Pulmonary Adenocarcinoma Successfully Treated with Molecular Target Therapy.
Masataka Yamaoka, Tsutomu Igarashi, Naka Shiratori, Keiki Miyadera, Teppei Sugano

Case Rep Ophthalmol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer.
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Takeru Kashiwada

Gene· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma.
Akiko Takahashi, Rintaro Noro, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi, Teppei Sugano

Mol Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute respiratory failure due to infection with acute fibrinous and organazing pneumonia: A case report.
Ken Okamura, Rintaro Noro, Kazue Fujita, Shoko Kure, Shinobu Kunugi, Teppei Sugano

Respir Med Case Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics of kidney injury in non-small cell lung cancer patients under combination therapy including pembrolizumab.
Sae Aratani, Teppei Sugano, Akira Shimizu, Masahiro Seike, Tetsuya Kashiwagi

CEN Case Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Molecular Target in -mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed.
Natsuki Takano, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Kakeru Hisakane

Anticancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Akiko Yoshikawa, Kuniko Matsuda

Thorac Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Shinobu Kunugi

Anticancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling.
Satoshi Takahashi, Rintaro Noro, Masahiro Seike, Chao Zeng, Masaru Matsumoto, Teppei Sugano

Int J Mol Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer.
Shunichi Nishima, Akihiko Miyanaga, Sho Saito, Mizuki Yuasa, Satoshi Takahashi, Teppei Sugano

Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Toru Hirozane, Mari Masuda, Teppei Sugano, Tetsuya Sekita, Naoko Goto

JCI Insight· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846.
Teppei Sugano, Mari Masuda, Fumitaka Takeshita, Noriko Motoi, Toru Hirozane

Br J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma.
Teppei Sugano, Masayuki Yoshida, Mari Masuda, Makiko Ono, Kenji Tamura

Br J Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer.
Teppei Sugano, Masahiro Seike, Yoshinobu Saito, Takeru Kashiwada, Yasuhiro Terasaki

Thorac Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
Aya Fukuizumi, Yuji Minegishi, Miwako Omori, Kenichiro Atsumi, Natsuki Takano, Teppei Sugano

Int J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer.
Takeru Kashiwada, Yoshinobu Saito, Yasuhiro Terasaki, Kakeru Hisakane, Susumu Takeuchi, Teppei Sugano

Jpn J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
Teppei Sugano, Masahiro Seike, Yoko Funasaka, Mai Yoshida, Ryoko Takayama

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis.
Takehiro Tozuka, Teppei Sugano, Rintaro Noro, Natsuki Takano, Kakeru Hisakane

Oxf Med Case Reports· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression.
Takehiro Tozuka, Masahiro Seike, Yuji Minegishi, Shingo Kitagawa, Tomomi Kato, Teppei Sugano

Onco Targets Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab.
Teppei Sugano, Masahiro Seike, Rintaro Noro, Syota Kaburaki, Takehiro Tozuka

Onco Targets Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.
Nobuhiko Nishijima, Masahiro Seike, Chie Soeno, Mika Chiba, Akihiko Miyanaga, Teppei Sugano

Int J Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
Teppei Sugano, Masahiro Seike, Rintaro Noro, Chie Soeno, Mika Chiba

Mol Cancer Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.
Masaru Matsumoto, Masahiro Seike, Rintaro Noro, Chie Soeno, Teppei Sugano

BMC Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ovarian cancer: TC therapy].
Teppei Sugano, Noriyuki Katsumata

Nihon Rinsho· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Rintaro Noro, Masahiro Seike, Fenfei Zou, Chie Soeno, Kuniko Matsuda, Teppei Sugano

BMC Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis